GB0819633D0 - Composition - Google Patents

Composition

Info

Publication number
GB0819633D0
GB0819633D0 GBGB0819633.9A GB0819633A GB0819633D0 GB 0819633 D0 GB0819633 D0 GB 0819633D0 GB 0819633 A GB0819633 A GB 0819633A GB 0819633 D0 GB0819633 D0 GB 0819633D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0819633.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0819633.9A priority Critical patent/GB0819633D0/en
Publication of GB0819633D0 publication Critical patent/GB0819633D0/en
Priority to JP2011532725A priority patent/JP5676458B2/ja
Priority to PL18209661.0T priority patent/PL3501534T3/pl
Priority to HRP20240226TT priority patent/HRP20240226T1/hr
Priority to RU2011120706/10A priority patent/RU2559528C2/ru
Priority to CN2009801480003A priority patent/CN102245202A/zh
Priority to CN201510119007.XA priority patent/CN105412920A/zh
Priority to FIEP18209661.0T priority patent/FI3501534T3/fi
Priority to NZ601538A priority patent/NZ601538A/en
Priority to DK18209661.0T priority patent/DK3501534T5/da
Priority to KR1020197002691A priority patent/KR20190011836A/ko
Priority to EP09753188.3A priority patent/EP2355845B1/en
Priority to SI200932190T priority patent/SI3501534T1/sl
Priority to MX2011004322A priority patent/MX2011004322A/es
Priority to KR1020117011885A priority patent/KR20110092282A/ko
Priority to AU2009306114A priority patent/AU2009306114B2/en
Priority to KR1020167035443A priority patent/KR20170000390A/ko
Priority to US13/125,957 priority patent/US20120052092A1/en
Priority to NZ592444A priority patent/NZ592444A/xx
Priority to PT182096610T priority patent/PT3501534T/pt
Priority to PCT/GB2009/051439 priority patent/WO2010046715A1/en
Priority to BRPI0919926A priority patent/BRPI0919926A2/pt
Priority to HUE18209661A priority patent/HUE065348T2/hu
Priority to EP18209661.0A priority patent/EP3501534B1/en
Priority to ES18209661T priority patent/ES2970878T3/es
Priority to CA2741619A priority patent/CA2741619A1/en
Priority to LTEP18209661.0T priority patent/LT3501534T/lt
Priority to CO11055224A priority patent/CO6382140A2/es
Priority to JP2014261910A priority patent/JP6076326B2/ja
Priority to AU2015275311A priority patent/AU2015275311B2/en
Priority to AU2017245320A priority patent/AU2017245320B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0819633.9A 2008-10-25 2008-10-25 Composition Ceased GB0819633D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition
LTEP18209661.0T LT3501534T (lt) 2008-10-25 2009-10-26 Vakcinos kompozicijos, apimančios mutuotą, faktorių h surišantį baltymą
KR1020117011885A KR20110092282A (ko) 2008-10-25 2009-10-26 돌연변이 인자 ｈ 결합 단백질을 포함하는 백신 조성물
AU2009306114A AU2009306114B2 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor H binding protein
HRP20240226TT HRP20240226T1 (hr) 2008-10-25 2009-10-26 Pripravci cjepiva koji sadrže protein vezivanja mutiranog faktora h
RU2011120706/10A RU2559528C2 (ru) 2008-10-25 2009-10-26 КОМПОЗИЦИИ ВАКЦИН ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ИЛИ ЗАБОЛЕВАНИЯ, ВЫЗЫВАЕМЫХ Neisseria meningitides И/ИЛИ Neisseria gonorrhoeae, СОДЕРЖАЩИЕ МУТИРОВАННЫЙ БЕЛОК, СВЯЗЫВАЮЩИЙ ФАКТОР Н
CN2009801480003A CN102245202A (zh) 2008-10-25 2009-10-26 含有突变型h因子结合蛋白的疫苗组合物
CN201510119007.XA CN105412920A (zh) 2008-10-25 2009-10-26 含有突变型ｈ因子结合蛋白的疫苗组合物
FIEP18209661.0T FI3501534T3 (fi) 2008-10-25 2009-10-26 Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia
NZ601538A NZ601538A (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
DK18209661.0T DK3501534T5 (da) 2008-10-25 2009-10-26 Vaccinesammensætninger omfattende en muteret faktor h-bindende protein
KR1020197002691A KR20190011836A (ko) 2008-10-25 2009-10-26 돌연변이 인자 ｈ 결합 단백질을 포함하는 백신 조성물
EP09753188.3A EP2355845B1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
SI200932190T SI3501534T1 (sl) 2008-10-25 2009-10-26 Cepivni sestavki, ki obsegajo mutiran vezavni protein faktorja h
MX2011004322A MX2011004322A (es) 2008-10-25 2009-10-26 Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada.
JP2011532725A JP5676458B2 (ja) 2008-10-25 2009-10-26 変異ｈ因子結合タンパク質を含むワクチン組成物
KR1020167035443A KR20170000390A (ko) 2008-10-25 2009-10-26 돌연변이 인자 ｈ 결합 단백질을 포함하는 백신 조성물
PT182096610T PT3501534T (pt) 2008-10-25 2009-10-26 Composições de vacina que compreendem uma proteína de ligação de fator h mutada
PL18209661.0T PL3501534T3 (pl) 2008-10-25 2009-10-26 Kompozycje szczepionkowe zawierające zmutowane białko wiążące czynnik h
NZ592444A NZ592444A (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
US13/125,957 US20120052092A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
PCT/GB2009/051439 WO2010046715A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
BRPI0919926A BRPI0919926A2 (pt) 2008-10-25 2009-10-26 composição de vacina que compreendem uma proteína de ligação do fator h mutada
HUE18209661A HUE065348T2 (hu) 2008-10-25 2009-10-26 Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények
EP18209661.0A EP3501534B1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
ES18209661T ES2970878T3 (es) 2008-10-25 2009-10-26 Composiciones de vacuna que comprenden una proteína de unión al factor H mutada
CA2741619A CA2741619A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
CO11055224A CO6382140A2 (es) 2008-10-25 2011-05-05 Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada
JP2014261910A JP6076326B2 (ja) 2008-10-25 2014-12-25 変異ｈ因子結合タンパク質を含むワクチン組成物
AU2015275311A AU2015275311B2 (en) 2008-10-25 2015-12-23 Vaccine compositions comprising a mutated factor h binding protein
AU2017245320A AU2017245320B2 (en) 2008-10-25 2017-10-10 Vaccine compositions comprising a mutated factor h binding protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition

Publications (1)

Publication Number Publication Date
GB0819633D0 true GB0819633D0 (en) 2008-12-03

Family

ID=40133849

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0819633.9A Ceased GB0819633D0 (en) 2008-10-25 2008-10-25 Composition

Country Status (23)

Country Link
US (1) US20120052092A1 (enExample)
EP (2) EP3501534B1 (enExample)
JP (2) JP5676458B2 (enExample)
KR (3) KR20170000390A (enExample)
CN (2) CN102245202A (enExample)
AU (1) AU2009306114B2 (enExample)
BR (1) BRPI0919926A2 (enExample)
CA (1) CA2741619A1 (enExample)
CO (1) CO6382140A2 (enExample)
DK (1) DK3501534T5 (enExample)
ES (1) ES2970878T3 (enExample)
FI (1) FI3501534T3 (enExample)
GB (1) GB0819633D0 (enExample)
HR (1) HRP20240226T1 (enExample)
HU (1) HUE065348T2 (enExample)
LT (1) LT3501534T (enExample)
MX (1) MX2011004322A (enExample)
NZ (2) NZ592444A (enExample)
PL (1) PL3501534T3 (enExample)
PT (1) PT3501534T (enExample)
RU (1) RU2559528C2 (enExample)
SI (1) SI3501534T1 (enExample)
WO (1) WO2010046715A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX343752B (es) 1998-05-01 2016-11-22 Novartis Vaccines & Diagnostics Inc Antigenos de neisseria meningitidis y composiciones que los contienen.
EP1179072A2 (en) 1999-05-19 2002-02-13 Chiron S.P.A. Combination neisserial compositions
PT2275551E (pt) 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
PT2270030E (pt) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Expressão heteróloga de proteínas de neisseria
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
EP2351579B1 (en) 2002-10-11 2016-09-21 Novartis Vaccines and Diagnostics S.r.l. Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
AU2009215364B2 (en) 2008-02-21 2014-09-18 Glaxosmithkline Biologicals S.A. Meningococcal fHBP polypeptides
AU2009223613B2 (en) 2008-03-10 2014-09-25 Children's Hospital & Research Center At Oakland Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
CN104548082A (zh) 2009-03-24 2015-04-29 诺华股份有限公司 为脑膜炎球菌因子h结合蛋白添加佐剂
US9266942B2 (en) 2009-04-30 2016-02-23 Children's Hospital & Research Center Oakland Chimeric factor H binding proteins (fHbp) and methods of use
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
EP2544714A1 (en) * 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Vaccine composition
TR201802933T4 (tr) * 2010-03-30 2018-03-21 Childrens Hospital & Res Center At Oakland Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
WO2011161653A1 (en) 2010-06-25 2011-12-29 Novartis Ag Combinations of meningococcal factor h binding proteins
MX2014008988A (es) 2012-02-02 2014-08-27 Novartis Ag Promotores para aumento de expresion de proteinas en meningococo.
ES2847923T3 (es) 2012-06-14 2021-08-04 Glaxosmithkline Biologicals Sa Vacunas contra el meningococo del serogrupo X
CN104736563A (zh) 2012-07-27 2015-06-24 国家健康与医学研究院 Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附
US20160030544A1 (en) * 2013-03-14 2016-02-04 Isis Innovation Limited Immunogenic composition to neisseria
WO2015017817A1 (en) 2013-08-02 2015-02-05 Children's Hospital & Research Center Oakland Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof
CN106661092B (zh) 2014-02-28 2021-07-06 葛兰素史密丝克莱恩生物有限公司 修饰的脑膜炎球菌fHbp多肽
BR112017001417B1 (pt) 2014-07-23 2023-11-07 Children's Hospital & Research Center At Oakland Variantes da proteína de ligação ao fator h (fhbp), composição imunogênica e uso de uma fhbp variante referência cruzada
AU2015304079B2 (en) * 2014-08-20 2021-05-13 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
EP3897706A4 (en) 2018-12-21 2022-11-23 Griffith University COMPOSITIONS, METHODS AND USES FOR INDURING AN IMMUNE RESPONSE
AU2020309556A1 (en) * 2019-07-08 2022-03-03 Crapaud Bio, Inc. Methods of making and using lipooligosaccharide compositions and vaccines
JP7631296B2 (ja) 2019-07-17 2025-02-18 ジェミニ・セラピューティクス・サブ・インコーポレイテッド Ｈ因子増強性抗体及びその使用
TW202245836A (zh) 2021-02-19 2022-12-01 美商賽諾菲巴斯德公司 重組ｂ型腦膜炎球菌疫苗
TW202423477A (zh) 2022-08-03 2024-06-16 美商賽諾菲巴斯德公司 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
BRPI0409459A (pt) * 2003-04-16 2006-05-02 Wyeth Corp novas composições imunogênicas para a prevenção e tratamento de doença meningocócica
CN101107007B (zh) * 2005-01-27 2011-08-17 奥克兰儿童医院及研究中心 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
AU2007263531B2 (en) * 2006-06-29 2012-03-15 J. Craig Venter Institute, Inc. Polypeptides from neisseria meningitidis
WO2011024072A2 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
TR201802933T4 (tr) * 2010-03-30 2018-03-21 Childrens Hospital & Res Center At Oakland Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.

Also Published As

Publication number Publication date
SI3501534T1 (sl) 2024-03-29
AU2009306114B2 (en) 2015-10-01
BRPI0919926A2 (pt) 2016-02-16
KR20110092282A (ko) 2011-08-17
AU2009306114A1 (en) 2010-04-29
RU2559528C2 (ru) 2015-08-10
EP3501534A1 (en) 2019-06-26
DK3501534T3 (da) 2024-02-05
ES2970878T3 (es) 2024-05-31
CA2741619A1 (en) 2010-04-29
KR20170000390A (ko) 2017-01-02
HUE065348T2 (hu) 2024-05-28
CN102245202A (zh) 2011-11-16
PL3501534T3 (pl) 2024-04-02
PT3501534T (pt) 2024-02-07
JP6076326B2 (ja) 2017-02-08
EP3501534B1 (en) 2023-11-29
LT3501534T (lt) 2024-03-12
JP5676458B2 (ja) 2015-02-25
MX2011004322A (es) 2011-06-16
JP2012506411A (ja) 2012-03-15
EP2355845B1 (en) 2018-12-05
CO6382140A2 (es) 2012-02-15
NZ601538A (en) 2014-01-31
US20120052092A1 (en) 2012-03-01
KR20190011836A (ko) 2019-02-07
WO2010046715A1 (en) 2010-04-29
EP2355845A1 (en) 2011-08-17
HRP20240226T1 (hr) 2024-05-10
JP2015063558A (ja) 2015-04-09
CN105412920A (zh) 2016-03-23
FI3501534T3 (fi) 2024-02-09
RU2011120706A (ru) 2012-11-27
DK3501534T5 (da) 2024-09-02
NZ592444A (en) 2012-11-30

Similar Documents

Publication Publication Date Title
ZA201005268B (en) Composition
GB0815022D0 (en) Composition
GB0822246D0 (en) Composition
GB0818473D0 (en) Composition
GB0810554D0 (en) Herbicde composition
GB0801119D0 (en) Composition
GB0809808D0 (en) Composition
GB0818472D0 (en) Composition
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
ZA201102726B (en) Composition
PL2128199T3 (pl) Nowa kompozycja
GB0810359D0 (en) Composition
GB0817656D0 (en) Composition
GB0809983D0 (en) Composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
ZA201103080B (en) Composition
GB0821754D0 (en) Composition
GB0818231D0 (en) Composition
GB0813589D0 (en) Composition
GB0903681D0 (en) Composition
GB0823344D0 (en) Composition
GB0820259D0 (en) Composition
GB0818336D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)